HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
The PERT Consortium shared a proud post on X:
”We’re excited to share enrollment for HI-PEITHO is now complete! With 544 patients enrolled across 72 sites in the United States in Europe, this landmark trial compares EKOS (Ultrasound Assisted Thrombolysis) with Anticoagulation vs Anticoagulation Alone in the treatment of intermediate-high risk PE patients. The study was a collaboration between The PERT Consortium, University Medical Center Mainz, and Boston Scientific. We extend our congratulations to all investigators and enrollment sites involved in this one-of-a-kind trial that will inform strategies for PE treatment around the world.”
Learn more abouth the HI-PEITHO here.
Enrollment for the HIPEITHO trial has successfully concluded, with 544 patients enrolled across 72 clinical sites in the United States and Europe.
In HIPEITHO Trial, the pivotal, multicenter study compares ultrasound-assisted catheter-directed thrombolysis using the EKOS system plus anticoagulation versus anticoagulation alone in patients with intermediate-high risk pulmonary embolism (PE).
A collaboration between The PERT Consortium, University Medical Center Mainz, and Boston Scientific, HIPEITHO trial represents a major step forward in evaluating treatment strategies for PE.
The results are expected to significantly inform clinical decision-making and global PE management.
Congratulations to all investigators and sites for their contribution to this groundbreaking trial!
Find the latest scientific advancements in thrombosis management featured in Hemostasis Today.
-
May 7, 2026, 17:56The Latest Clinical Data Shaping The Evolving Landscape of Hemophilia Treatment – EAHAD
-
May 7, 2026, 17:31Talha Badar: New Classical Hematology Chapter on Bleeding and Thrombosis
-
May 7, 2026, 17:26Maria Τektonidou: Gene Network Analysis Identifies STAT1 in Thrombotic APS
-
May 7, 2026, 17:23Sonu Bhaskar: Inflammatory Biomarkers in Acute Cerebral Venous Sinus Thrombosis
-
May 7, 2026, 16:53Patricio S. Espinosa: Anticoagulation Is Not an Absolute Contraindication to Amyloid Therapy
-
May 7, 2026, 16:34Arun V J: Give Blood and Be the Hero You Always Wanted to Be
-
May 7, 2026, 16:15August Bones: When Would You Consider Placing an Inferior Vena Cava Filter After a Pulmonary Embolism?
-
May 7, 2026, 15:58Stop Asking Doctors to Do More – Reimagining the Care Team – The US Oncology
-
May 7, 2026, 15:42Chokri Ben Lamine: CVC-Associated UE-DVT and Catheter Removal